Crushed Prasugrel Improves Pharmacodynamics But Little Else: Where Are the Missing Pieces?

JACC Cardiovasc Interv. 2021 Jun 28;14(12):1334-1336. doi: 10.1016/j.jcin.2021.05.001.

Authors

Arka Chatterjee¹, Kristina Skinner²

Affiliations

¹ Division of Cardiology, Sarver Heart Center, University of Arizona College of Medicine, Tucson, Arizona, USA. Electronic address: arkachatterjee@email.arizona.edu.
² Division of Cardiology, Sarver Heart Center, University of Arizona College of Medicine, Tucson, Arizona, USA.

PMID: 34167673
DOI: 10.1016/j.jcin.2021.05.001

No abstract available

Keywords: percutaneous coronary intervention; pharmacodynamics; platelet reactivity.

Publication types

Editorial
Comment

MeSH terms

Humans
Platelet Aggregation Inhibitors* / adverse effects
Prasugrel Hydrochloride / adverse effects
Ticlopidine*
Treatment Outcome

Substances

Platelet Aggregation Inhibitors
Prasugrel Hydrochloride
Ticlopidine